Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated
- Ramzi Abboud
- , Jesse Keller
- , Michael Slade
- , John F. DiPersio
- , Peter Westervelt
- , Michael P. Rettig
- , Stephanie Meier
- , Todd A. Fehniger
- , Camille N. Abboud
- , Geoffrey L. Uy
- , Ravi Vij
- , Kathryn M. Trinkaus
- , Mark A. Schroeder
- , Rizwan Romee
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Section of Medical Oncology
- Division of Veterans Affairs
- Bursky Center for Human Immunology and Immunotherapy
- Division of Oncology
- Center of Regenerative Medicine
- DBBS - Immunology
- DBBS - Cancer Biology
- Section of Hematological Malignancies
- Mentorship to Enhance Development in Academia Program
Research output: Contribution to journal › Article › peer-review
136
Link opens in a new tab
Scopus
citations